Early development of accelerated graft coronary artery disease: risk factors and course
SZ Gao,
SA Hunt,
JS Schroeder,
EL Alderman,
IR Hill,
and
EB Stinson
Division of Cardiovascular Medicine, Stanford University School of Medicine, California 94305-5246, USA.
OBJECTIVES: This study assessed the time of first appearance of angiographic graft coronary artery disease in relation to clinical and laboratory variables and clinical events in heart transplant recipients. BACKGROUND: Graft coronary artery disease is the main factor limiting long-term survival after heart transplantation, and it is important to understand its natural history. METHODS: One hundred thirty-nine consecutive patients who developed angiographic coronary artery disease after heart transplantation were classified according to early (< or = 2 years) versus late (> 2 years) posttransplantation initial detection of coronary artery disease. These subgroups were analyzed for differences in clinical and laboratory demographics, incidence of progression to ischemic events and incidence of antecedent cytomegalovirus infection. RESULTS: The early-onset group (64 patients) had more rapid progression to ischemic events than the late-onset group (75 patients), with 59% of the late group and only 35% of the early group free from ischemic events by 5 years after initial detection (p = 0.02), but there were no significantly correlated clinical or laboratory predictors of ischemic events. The early group had a significantly higher incidence of antecedent cytomegalovirus infection. CONCLUSIONS: We conclude that 1) accelerated graft coronary artery disease develops at variable times after heart transplantation; 2) the early appearance of graft coronary artery disease may be a marker of intrinsically more aggressive disease; 3) cytomegalovirus infection is associated with earlier onset of graft coronary artery disease. Patients with early development of graft coronary artery disease should potentially be given priority for interventional strategies as they are developed.
This article has been cited by other articles:

|
 |

|
 |
 
E. Larose, D. Behrendt, S. Kinlay, A. P. Selwyn, P. Ganz, and J. C. Fang
Endothelin-1 Is a Key Mediator of Coronary Vasoconstriction in Patients With Transplant Coronary Arteriosclerosis
Circ Heart Fail,
September 1, 2009;
2(5):
409 - 416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hussain, M. Burch, M. J. Fenton, P. M. Whitmore, P. Rees, M. Elliott, and P. Aurora
Positive Pretransplantation Cytomegalovirus Serology Is a Risk Factor for Cardiac Allograft Vasculopathy in Children
Circulation,
April 3, 2007;
115(13):
1798 - 1805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Furukawa, P. Libby, J. L. Stinn, G. Becker, and R. N. Mitchell
Cold Ischemia Induces Isograft Arteriopathy, but Does Not Augment Allograft Arteriopathy in Non-Immunosuppressed Hosts
Am. J. Pathol.,
March 1, 2002;
160(3):
1077 - 1087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Kapadia, S. E. Nissen, K. M. Ziada, G. Rincon, T. D. Crowe, N. Boparai, J. B. Young, and E. M. Tuzcu
Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study
J. Am. Coll. Cardiol.,
July 1, 2001;
38(1):
206 - 213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Baum
Weight Gain and Cardiovascular Risk After Organ Transplantation
JPEN J Parenter Enteral Nutr,
May 1, 2001;
25(3):
114 - 119.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Dal Canto, H. W. Virgin IV, and S. H. Speck
Ongoing Viral Replication Is Required for Gammaherpesvirus 68-Induced Vascular Damage
J. Virol.,
December 1, 2000;
74(23):
11304 - 11310.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Sharifi, Y. Siraj, J. O'Donnell, and V. J. Pompili
Coronary Angioplasty and Stenting in Orthotopic Heart Transplants: A Fruitful Act or a Futile Attempt?
Angiology,
October 1, 2000;
51(10):
809 - 815.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Labarrere, D. R. Nelson, S. J. Miller, J. M. Nieto, J. A. Conner, D. E. Pitts, P. C. Kirlin, and H. G. Halbrook
Value of Serum-Soluble Intercellular Adhesion Molecule-1 for the Noninvasive Risk Assessment of Transplant Coronary Artery Disease, Posttransplant Ischemic Events, and Cardiac Graft Failure
Circulation,
September 26, 2000;
102(13):
1549 - 1555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Cooke, G. M. Eaton, G. Whitby, R. A. Kennedy, P. F. Binkley, M. L. Moeschberger, and C. V. Leier
Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients
J. Am. Coll. Cardiol.,
August 1, 2000;
36(2):
509 - 516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Labarrere, D. R. Nelson, C. J. Cox, D. Pitts, P. Kirlin, and H. Halbrook
Cardiac-Specific Troponin I Levels and Risk of Coronary Artery Disease and Graft Failure Following Heart Transplantation
JAMA,
July 26, 2000;
284(4):
457 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Y. Wang, I. Aronson, S. Takuma, S. Homma, Y. Naka, T. Alshafie, V. Brovkovych, T. Malinski, M. C. Oz, and D. J. Pinsky
cAMP Pulse During Preservation Inhibits the Late Development of Cardiac Isograft and Allograft Vasculopathy
Circ. Res.,
May 12, 2000;
86(9):
982 - 988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. G. Sia and R. Patel
New Strategies for Prevention and Therapy of Cytomegalovirus Infection and Disease in Solid-Organ Transplant Recipients
Clin. Microbiol. Rev.,
January 1, 2000;
13(1):
83 - 121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lindelow, C.-H. Bergh, C. Lamm, B. Andersson, and F. Waagstein
Graft coronary artery disease is strongly related to the aetiology of heart failure and cellular rejections
Eur. Heart J.,
September 2, 1999;
20(18):
1326 - 1334.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F. HALLORAN, A. MELK, and C. BARTH
Rethinking Chronic Allograft Nephropathy: The Concept of AcceleratedSenescence
J. Am. Soc. Nephrol.,
January 1, 1999;
10(1):
167 - 181.
[Full Text]
|
 |
|

|
 |

|
 |
 
C. A. Labarrere, D. R. Nelson, and W. P. Faulk
Endothelial Activation and Development of Coronary Artery Disease in Transplanted Human Hearts
JAMA,
October 8, 1997;
278(14):
1169 - 1175.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Allan, J. K. Choo, L. Vesga, J. S. Arn, M. R. Pins, D. H. Sachs, and J. C. Madsen
Cardiac Allograft Vasculopathy Is Abrogated by Anti-CD8 Monoclonal Antibody Therapy
Ann. Thorac. Surg.,
October 1, 1997;
64(4):
1019 - 1025.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Weis and W. von Scheidt
Cardiac Allograft Vasculopathy : A Review
Circulation,
September 16, 1997;
96(6):
2069 - 2077.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Early Graft CAD Due to Virus?
Journal Watch Cardiology,
November 8, 1996;
1996(1108):
8 - 8.
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Y. Wang, S. P. Mazer, K. Minamoto, S. Takuma, S. Homma, M. Yellin, L. Chess, A. Fard, S. L. Kalled, M. C. Oz, et al.
Suppression of Murine Cardiac Allograft Arteriopathy by Long-Term Blockade of CD40-CD154 Interactions
Circulation,
April 2, 2002;
105(13):
1609 - 1614.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|